机构:[a]Key Laboratory of Biotechnology of Antibiotics, National Health Commission (NHC), Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China[b]Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[c]Institute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing, China首都医科大学宣武医院脑血管病研究室[d]Postdoctoral Scientific Research Workstation, China Resources Sanjiu Medical and Pharmaceutical Co., Ltd., Shenzhen, China[e]Postdoctoral Mobile Research Station, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China[f]National Institutes for Food and Drug Control, Graduate School of Peking Union Medical College, Beijing, China
CAMS Initiative for Innovative Medicine [2016-I2M-1-011]; Foundation for Innovative Research Groups of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81621064]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81603172]
Chen B,Zheng Y.-M,Zhang M.-Q,et al.Microarray expression profiling and Raman spectroscopy reveal anti-fatty liver action of berberine in a diet-induced larval zebrafish model[J].FRONTIERS IN PHARMACOLOGY.2020,10:1504.doi:10.3389/fphar.2019.01504.
APA:
Chen, B,Zheng, Y.-M,Zhang, M.-Q,Han, Y,Zhang, J.-P&Hu, C.-Q.(2020).Microarray expression profiling and Raman spectroscopy reveal anti-fatty liver action of berberine in a diet-induced larval zebrafish model.FRONTIERS IN PHARMACOLOGY,10,
MLA:
Chen, B,et al."Microarray expression profiling and Raman spectroscopy reveal anti-fatty liver action of berberine in a diet-induced larval zebrafish model".FRONTIERS IN PHARMACOLOGY 10.(2020):1504